Revenues of $263.5 million for the quarter ended January 25, 2026; operating earnings of $8.2 million; and net loss from continuing operations of $0.2 million (0.00 $ per share). Adjusted operating ...
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
Allspring Core Plus Bond Fund underperformed the Bloomberg U.S. Aggregate Bond Index benchmark for the quarter. Read more ...
The Silvant Large Cap Growth SMA returned +2.69% (gross)/+1.94% (net) for the quarter, outperforming the Russell 1000 Growth Index's return of +1.12%. Read more here.
Voyager Technologies, Inc. (NYSE: VOYG) (“Voyager” or the “Company”), today announced financial results for the fourth quarter and full year 2025. Based on record year-end 2025 Backlog of $265.6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results